Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameJinhai Med Tech
Stock Code02225
Company Full NameTo be extracted
IndustryInformation Technology
Principal Activities主要在新加坡向建築及建造承包商提供勞務派遣及配套服務;亦提供宿舍服務、資訊科技服務及建造配套服務(包括倉儲服務、清潔服務及樓宇保養工程等)
Listing Date2017-10-17
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)21B Senoko Loop, Singapore 758171
Business Address (Hong Kong)香港中環皇后大道中29號華人行16樓1603室
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitekttgroup.com.sg
Share Registrar宝德隆
Registrar Contact(852)2153 1688
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism To be extracted
Offer PriceHK$ 0.52 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer Period2017-10-10 to 2017-10-10
Global Offering Shares307,500,000 shares
HK Public Offer Shares (Initial)30,750,000 shares (10.0%)
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)276,750,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO1,230,000,000 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone ShareNo cornerstone investors
Clawback TiersTo be extracted
Reallocation OptionNo
Total Global Offering SizeHK$ 159,900,000

Stock Connect Inclusion Analysis

Avg Daily HK Mkt Cap HK$ 18.88B
Analysis Result Already included in Stock Connect (both)

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss Status盈利約6.6百萬新加坡元
Period-End Cash Balance新加坡元15.7百萬元
Listing Expenses~HK$ 21,400,000
Listing Expenses / Funds Raised~13.38%
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: RMB
Income Statement
Item 2014201520162017-04
Revenue 45,095,23046,091,35445,050,83615,038,871
Cost of sales -28,350,961-30,803,312-29,538,360-10,030,111
Gross profit 16,744,26915,288,04215,512,4765,008,760
Other income and gains, net 431,480523,240823,711312,142
Selling and distribution expenses -283,515-50,422-52,055-8,887
Administrative expenses -8,419,926-7,550,605-7,894,256-2,325,718
Operating profit 4,881,8487,445,2057,598,7681,786,413
Net finance costs -54,110-31,856-17,227-1,405
Profit before tax 4,827,7387,413,3497,581,5411,785,008
Income tax expense -669,753-1,089,350-961,752-330,216
Profit for the year 4,157,9856,323,9996,619,7891,454,792
Balance Sheet
Item 2014201520162017-04
Cash and cash equivalents 15,382,98211,668,04415,723,6756,745,025
Trade and bills receivables 6,926,0275,417,6325,039,9607,326,721
Total current assets 22,998,39719,616,63923,112,47316,284,188
Total assets 27,227,93422,410,55926,547,49919,771,860
Total current liabilities 19,806,7589,154,06816,555,1748,328,040
Total liabilities 20,359,2249,217,85016,574,9878,344,556
Total equity 6,868,71013,192,7099,972,51211,427,304
Equity attributable to owners 6,868,71013,192,7099,972,51211,427,304
Interest-bearing borrowings 2,432,920552,46643,4390
Cash Flow Statement
Item 2014201520162017-04
Net cash from operating activities 8,903,5319,868,3657,528,915-1,007,446
Net cash from investing activities -242,283-1,583,765-41,121-314,590
Net cash from financing activities -3,511,784-11,999,538-3,432,163-7,656,614
Net increase in cash 5,149,464-3,714,9384,055,631-8,978,650
Depreciation of PP&E 681,641691,564641,711249,744
Purchase of PP&E -92,892-249,402-1,253,613-317,790
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 0.55
First Day OpenHK$ 0.55
First Day Change5.77%
First Day Volume320870000.0
First Day Turnover180117000.0
Use of Proceeds
1、約77.1百萬港元,約93.4% 將部分用于為以估計代價162.0百萬港元(相當于約28.0百萬新加坡元,即建議收購事項估計代價范圍之中位數)增購一間外籍工人宿舍提供資金; 2、約5.5百萬港元,約6.6%將用于為增購10輛卡車提供資金,以應對根據我們的業務擴張計劃,勞工人數增加預期帶來的運輸需求增加的情況。

Underwriting Syndicate

Sole Sponsor (1)
Dakin Capital Limited CE BGC821
Joint Bookrunners (2)
ChaoShang Securities Limited CE BGH629 Alpha Financial Group Limited CE ALW542
Joint Lead Managers (6)
ChaoShang Securities Limited CE BGH629 Alpha Financial Group Limited CE ALW542 Kai Yin Securities Limited CE BHC102 GRANSING SECURITIES CO., LIMITED CE AER434 KOALA SECURITIES LIMITED CE BFI038 Sino-Rich Securities & Futures Limited CE AFN604

Cornerstone Investors

This stock has no cornerstone investors.

Directors & Management

PositionChinese nameEnglish Name
Chairman柯安錠—
Company Secretary郭兆文—
No director data available.

Major Shareholders

Major Shareholders & HoldingsMighty One Investments Limited 實益持有75%股份;柯安錠先生透過Mighty One持有75%;柯夫人作為配偶被視為持有75%
About this page

This page shows Jinhai Med Tech (02225) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect